Polidocanol (Intravenous Route)
Name: Polidocanol (Intravenous Route)
- Polidocanol Intravenous Route brand name
- Polidocanol Intravenous Route dosage
- Polidocanol Intravenous Route dosage forms
- Polidocanol Intravenous Route injection
- Polidocanol Intravenous Route used to treat
- Polidocanol Intravenous Route is used to treat
US Brand Name
- Varithena
Descriptions
Polidocanol injection is used to treat small varicose veins of the lower legs. This medicine is also used to treat incompetent great saphenous veins, accessory saphenous veins, and visible varicose veins above and below the knees. It is a type of medicine called a sclerosing agent.
This medicine is to be given only by or under the direct supervision of your doctor.
This product is available in the following dosage forms:
- Solution
- Foam
Allergies
Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.
Other Interactions
Certain medicines should not be used at or around the time of eating food or eating certain types of food since interactions may occur. Using alcohol or tobacco with certain medicines may also cause interactions to occur. Discuss with your healthcare professional the use of your medicine with food, alcohol, or tobacco.
Other Medical Problems
The presence of other medical problems may affect the use of this medicine. Make sure you tell your doctor if you have any other medical problems, especially:
- Blood clots or
- Blood clotting disorders, acute—Should not be used in patients with these conditions.
- Blood clotting problems (eg, deep vein thrombosis, pulmonary embolism), history of or
- Major surgery, recent (within 3 months) or
- Prolonged immobilization—May increase risk for blood clotting problems.
- Blood vessel disease (eg, peripheral arteriosclerosis, thromboangiitis obliterans)—May increase risk for tissue ischemia.